Answering the questions of appropriate outcomes measures after intervention for deep reflux as promising...
"The path from initial trials to meaningful clinical data will not be easy,” writes Fedor Lurie (Toledo, USA) of new venous valve technologies.
There is...
No longer a ‘one-trick shop’: Venous becomes core pillar of CX amidst field’s evolution
Charting the development of the Charing Cross (CX) venous and lymphatic programme from a sidebar event to becoming an “integral part” of the meeting’s...
Thrombectomy gold rush set to follow ATTRACT study, experts argue
At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...
MedTech Insights: “This is a pivotal year for us,” says VeinWay CEO
With seven compassionate-use cases under its belt and commercialization in view, VeinWay—developer of the Traversa, a tool for crossing tough venous occlusions—is at a...
